In fact, tumor cells transformed to express IL-10 are rejected in immunocompetent hosts [49] and transplantable tumors injected into genetically transformed mice to express human IL-10 in myeloid cells were rejected, depending on the presence of CD8+ T cells in the host [50]. Here, IL10 is linked to neoplasm.